Company and Case Information

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors


Register


_______________
Copyright (c) 2001
Stanford Law School


Tibet Pharmaceuticals, Inc.
Summary: According to the law firm press release, the Complaint asserts violations of the federal securities laws against Tibet Pharma, its officers and directors, and underwriters for issuing inaccurate statements of material fact about the Company’s true financial and business condition, which ultimately caused the Tibet Pharma’s stock to be halted by the NASDAQ and delisted, causing investors to lose nearly their entire investment. The Complaint alleges defendants misrepresented and failed to disclose material internal control deficiencies, which rendered the Company’s registration statement and prospectus to be materially false and misleading.

On January 9, 2013, the Court issued an Order consolidating cases.

On February 27, 2013, the Court issued an Order appointing lead plaintiffs and approving the selection of lead counsel.

On May 1, 2013, the Lead Plaintiffs filed their Consolidated Amended Class Action Complaint.

INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Biotechnology & Drugs


COMPANY/ISSUER NAME: Tibet Pharmaceuticals, Inc.
COMPANY/ISSUER TICKER: TBET
COMPANY WEBSITE: http://www.tibetpharmaceuticals.com

FIRST IDENTIFIED COMPLAINT IN THE DATABASE
Ming Yang, et al. v. Tibet Pharmaceuticals, Inc., et al.
 COURT: D. Virgin Islands  DOCKET NUMBER: 12-CV-00054
 JUDGE NAME: 
 DATE FILED: 05/25/2012  SOURCE: 
 CLASS PERIOD START: 12/28/2010  CLASS PERIOD END: 05/25/2012
 TYPE OF COMPLAINT: Complaint (Unamended and Unconsolidated)
 PLAINTIFF FIRMS NAMED IN COMPLAINT:
  • Law Offices Of Joel Holt
      2132 Company Street, Suite 2, St. Croix, , 00820
       (voice) 340-773-8079, (fax) 340-773-8677, holtvi@aol.com
  • The Rosen Law Firm, P.A. (New York)
      350 Fifth Avenue, Suite 5508, New York, NY, 10118
       (voice) 212.686.1060, (fax) 212.202.3827, lrosen@rosenlegal.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  2

  •  DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
    Complaint Class Action
    Type: Complaint Date on the document: 05/25/2012
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 05/31/2012
    Order
    Type: Order of Consolidation Date on the document: 01/09/2013
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 01/09/2013
    Order
    Type: Order Appointing LP/LC Date on the document: 02/27/2013

    REFERENCE COMPLAINT
    Ming Yang, et al. v. Tibet Pharmaceuticals, Inc., et al.
     COURT: D. Virgin Islands  DOCKET NUMBER: 12-CV-00054
     JUDGE NAME: 
     DATE FILED: 05/01/2013  SOURCE: 
     CLASS PERIOD START: 01/24/2011  CLASS PERIOD END: 04/03/2012
     TYPE OF COMPLAINT: First Amended and Consolidated
     PLAINTIFF FIRMS NAMED IN COMPLAINT:
  • Bernstein Litowitz Berger & Grossmann LLP (New York, NY)
      1285 Avenue of the Americas, 33rd Floor, New York, NY, 10019
       (voice) 212.554.1400, (fax) 212.554.1444, blbg@blbglaw.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  1

  •  DOCUMENTS FOR THE REFERENCE COMPLAINT
    Jury Trial Demanded
    Type: Complaint Date on the document: 05/01/2013
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 05/03/2013

     OTHER DOCUMENTS
    Case Name and/or Number: 
    Type:  Date on the document: 

    WARNING AND DISCLAIMER OF LIABILITY:
    The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
    Go to Search  page | Go to Case Index  page | Back to Top